ACE and hydrops fetalis: There were slight differences in adherence to pathogenetic HF medications at discharge: Beta-blockers were prescribed for 81.9% of our patients and 89% of the CRT Survey II participants, ACE inhibitor or ARB blockers for 69.7% vs. 89%, and mineralocorticoid antagonist for 66.7% vs. 63%, respectively [30].